DK174112B1 - Cardiodilatinfragment benævnt urodilatin, fremgangsmåde til fremstilling deraf, lægemiddel indeholdende det, fremgangsmåde til bestemmelse af cardiodilatin samt anvendelse af urodilatin til fremstilling af diagnostika samt til fremstilling af lægemidler - Google Patents

Cardiodilatinfragment benævnt urodilatin, fremgangsmåde til fremstilling deraf, lægemiddel indeholdende det, fremgangsmåde til bestemmelse af cardiodilatin samt anvendelse af urodilatin til fremstilling af diagnostika samt til fremstilling af lægemidler Download PDF

Info

Publication number
DK174112B1
DK174112B1 DK198806108A DK610888A DK174112B1 DK 174112 B1 DK174112 B1 DK 174112B1 DK 198806108 A DK198806108 A DK 198806108A DK 610888 A DK610888 A DK 610888A DK 174112 B1 DK174112 B1 DK 174112B1
Authority
DK
Denmark
Prior art keywords
anf
cdd
urodilatine
arg
disorders
Prior art date
Application number
DK198806108A
Other languages
Danish (da)
English (en)
Other versions
DK610888D0 (da
DK610888A (da
Inventor
Gerhard Becker
Wolf-Georg Forssmann
Jeanette M Alt
Franz Herbst
Original Assignee
Wolf-Georg Forssmann
Bissendorf Peptide Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19873706731 external-priority patent/DE3706731A1/de
Priority claimed from DE19873717329 external-priority patent/DE3717329A1/de
Application filed by Wolf-Georg Forssmann, Bissendorf Peptide Gmbh filed Critical Wolf-Georg Forssmann
Publication of DK610888D0 publication Critical patent/DK610888D0/da
Publication of DK610888A publication Critical patent/DK610888A/da
Application granted granted Critical
Publication of DK174112B1 publication Critical patent/DK174112B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
DK198806108A 1987-03-02 1988-11-02 Cardiodilatinfragment benævnt urodilatin, fremgangsmåde til fremstilling deraf, lægemiddel indeholdende det, fremgangsmåde til bestemmelse af cardiodilatin samt anvendelse af urodilatin til fremstilling af diagnostika samt til fremstilling af lægemidler DK174112B1 (da)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
DE19873706731 DE3706731A1 (de) 1987-03-02 1987-03-02 Neues cardiodilatinfragment und verfahren zur gewinnung von cardiodilatinfragmenten
DE3706731 1987-03-02
DE19873717329 DE3717329A1 (de) 1987-05-22 1987-05-22 Neues cardiodilatinfragment, verfahren zu seiner gewinnung und seine verwendung
DE3717329 1987-05-22
DE3741641 1987-12-09
DE3741641 1987-12-09
PCT/EP1988/000144 WO1988006596A1 (en) 1987-03-02 1988-02-27 New cardiodilatin fragment, process for preparing same and use thereof
EP8800144 1988-02-27

Publications (3)

Publication Number Publication Date
DK610888D0 DK610888D0 (da) 1988-11-02
DK610888A DK610888A (da) 1988-11-02
DK174112B1 true DK174112B1 (da) 2002-06-24

Family

ID=27195544

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198806108A DK174112B1 (da) 1987-03-02 1988-11-02 Cardiodilatinfragment benævnt urodilatin, fremgangsmåde til fremstilling deraf, lægemiddel indeholdende det, fremgangsmåde til bestemmelse af cardiodilatin samt anvendelse af urodilatin til fremstilling af diagnostika samt til fremstilling af lægemidler

Country Status (7)

Country Link
EP (1) EP0349545B1 (ja)
JP (1) JP2819467B2 (ja)
AT (1) ATE85345T1 (ja)
AU (1) AU614738B2 (ja)
DE (1) DE3878231T2 (ja)
DK (1) DK174112B1 (ja)
WO (1) WO1988006596A1 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262521A (en) * 1991-06-07 1993-11-16 Sri International Isolated atrial peptide-degrading enzyme and novel compounds useful as inhibitors thereof
DE4216133A1 (de) * 1992-05-15 1993-11-18 Bissendorf Peptide Gmbh Anwendung von Urodilatin bei Lungen- und Bronchialerkrankungen
US5665704A (en) * 1993-11-12 1997-09-09 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5846932A (en) * 1993-11-12 1998-12-08 Genentech, Inc. Receptor specific atrial natriuretic peptides
US6525022B1 (en) 1993-11-12 2003-02-25 Genentech, Inc. Receptor specific atrial natriuretic peptides
ATE226960T1 (de) * 1994-06-02 2002-11-15 Forssmann Wolf Georg Verfahren zur herstellung von cardiodilatin- fragmenten, hochgereinigte cardiodilatin- fragmente und zwischenprodukte zu deren herstellung
DE19535445A1 (de) * 1995-09-23 1997-03-27 Boehringer Mannheim Gmbh Verfahren zur Herstellung von natriuretischen Peptiden über Streptavidin-Fusionsproteine
AU7566396A (en) * 1995-11-16 1997-06-05 Boehringer Mannheim Gmbh Process for the preparation of peptides by way of streptavidin fusion proteins
DE19951471A1 (de) * 1999-10-26 2001-05-03 Forssmann Wolf Georg Verwendung von Urodilatin zur Behandlung chronischer Niereninsuffizienz mit Nierenrestfunktionen
DE10116552A1 (de) 2001-04-03 2002-10-10 Abc Armbruster Biochemicals Verfahren zur Bestimmung der wirksamen Parathormon-Aktivität in einer Probe
PL1865976T3 (pl) 2005-04-07 2012-11-30 Cardiorentis Ag Zastosowanie peptydu natriuretycznego do leczenia niewydolności serca
AU2007233116B2 (en) 2006-03-30 2013-05-09 Palatin Technologies, Inc. Cyclic natriuretic peptide constructs
US8580746B2 (en) 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
EP2004633A4 (en) 2006-03-30 2009-08-26 Palatin Technologies Inc LINEAR CONSTRUCTIONS OF NATRIURETIC PEPTIDES
EP2185183B1 (en) * 2007-09-11 2016-03-16 Cardiopep Pharma GmbH Use of natriuretic peptides for treating angioedema syndromes
EP2631247A1 (en) 2012-02-22 2013-08-28 Immundiagnostik AG Means and methods of measuring parathyroid hormone in patients suffering from oxidative stress
ES2689193T3 (es) 2013-03-08 2018-11-08 Immundiagnostik Ag La hormona paratiroidea biológica activa no oxidada determina mortalidad en pacientes en hemodiálisis
EP3740762A1 (en) 2018-01-17 2020-11-25 Immundiagnostik AG Biomarker predicting coronary artery disease
FR3099056B1 (fr) * 2019-07-26 2022-08-12 Univ Rouen Normandie Utilisation de l’ANP pour détruire les biofilms bactériens

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3588006T2 (de) * 1984-04-19 1995-08-10 Scios Nova Inc Atrielle natriumuretische/gefässerweiterende polypeptide.
DE3443257A1 (de) * 1984-11-28 1986-05-28 Bissendorf Peptide GmbH, 3002 Wedemark Mittel enthaltend vollsynthetisches alpha-humanes atriales natriuretisches peptid (alpha-hanap)

Also Published As

Publication number Publication date
EP0349545A1 (en) 1990-01-10
JPH02502636A (ja) 1990-08-23
AU614738B2 (en) 1991-09-12
DK610888D0 (da) 1988-11-02
DK610888A (da) 1988-11-02
DE3878231T2 (de) 1993-05-27
JP2819467B2 (ja) 1998-10-30
AU1348188A (en) 1988-09-26
ATE85345T1 (de) 1993-02-15
DE3878231D1 (de) 1993-03-18
EP0349545B1 (en) 1993-02-03
WO1988006596A1 (en) 1988-09-07

Similar Documents

Publication Publication Date Title
DK174112B1 (da) Cardiodilatinfragment benævnt urodilatin, fremgangsmåde til fremstilling deraf, lægemiddel indeholdende det, fremgangsmåde til bestemmelse af cardiodilatin samt anvendelse af urodilatin til fremstilling af diagnostika samt til fremstilling af lægemidler
US5665861A (en) Cardiodilatin fragment, process for preparing same and use thereof
US5847066A (en) Analogs of growth hormone-releasing factor
EP0489089B1 (en) Therapeutic peptides
EP0309297B1 (en) Therapeutic peptides
EP0438519B1 (en) Therapeutic peptides
US5049654A (en) Calcitonin gene related peptide derivatives
WO2012113286A1 (zh) 一种glp-1类似物、制备方法及其应用
EP0552238A1 (de) Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4716147A (en) Synthetic airial peptides
JPH06116284A (ja) 新規ペプチド
AU2003284428B2 (en) Peptides and medicinal compositions containing the same
JPH02174798A (ja) 細胞接着活性コア配列の繰り返し構造からなるポリペプチド
EP0173557A2 (en) Peptides
EP0687270B1 (en) Osteogenic growth oligopeptides and pharmaceutical compositions containing them
EP0182984B1 (en) Use of fully synthetic alpha-human atrial natriuretic peptide (alpha-hanap)
FI79716B (fi) Daeggdjur-pgrf.
EP0431113A1 (en) Atrial peptide derivatives
RU2120944C1 (ru) [(s) pmp1, d-trp2, pen6, arg8]окситоцин
EP0402313A1 (en) Novel endothelin derivative
JP2678993B2 (ja) 新規なアルキル化された成長ホルモン放出ペプチド及びそれにより哺乳動物を処理する方法
JP2001226284A (ja) 神経突起誘発剤
JP3042782B2 (ja) 心房性ナトリウム尿排泄亢進ペプチド類似化合物
JP2795346B2 (ja) 血管収縮ペプチド
JP2513440B2 (ja) 新規ペプチド

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK